Trial Profile
Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 06 Jan 2020 Status changed from completed to discontinued.
- 06 Sep 2019 Status changed from active, no longer recruiting to completed.
- 30 May 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Jul 2019.